Inventor
STERN MICHAEL E
US21 patents
⚠️ This page may combine multiple inventors who share the name “STERN MICHAEL E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALLERGAN INC
11 patentsUS5863892AJan 26, 1999
Use of platelet derived growth factor in ophthalmic wound healing
ALLERGAN INC71 citations94
US10065992B2Sep 4, 2018
Cyclosporin analogs
ALLERGAN INC3 citations70
US7368426B2May 6, 2008
Methods for the therapeutic use of cyclosporine components
ALLERGAN INC2 citations62
US7151085B2Dec 19, 2006
Therapeutic methods using cyclosporine components
ALLERGAN INC3 citations62
US7135455B2Nov 14, 2006
Methods for the therapeutic use of cyclosporine components
ALLERGAN INC2 citations62
US9493511B2Nov 15, 2016
Cyclosporin analogs
ALLERGAN INC2 citations60
US10736936B2Aug 11, 2020
Therapeutic methods using cyclosporine components
ALLERGAN INC0 citations52
US7902155B2Mar 8, 2011
Therapeutic methods using cyclosporine components
ALLERGAN INC0 citations52
US9561259B2Feb 7, 2017
Cyclosporin analogs
ALLERGAN INC0 citations48
US8821874B2Sep 2, 2014
KLK-13 antibody inhibitor for treating dry eye
ALLERGAN INC0 citations47
US10869955B2Dec 22, 2020
Joint fat pad formulations, and methods of use thereof
ALLERGAN INC0 citations37
STERN MICHAEL E
5 patentsUS4657727AApr 14, 1987
Fission product barrier emergency event classification and response system
STERN MICHAEL E21 citations74
US8491905B2Jul 23, 2013
KLK-13 antibody inhibitor for treating dry eye
STERN MICHAEL E1 citations55
US8211434B2Jul 3, 2012
KLK-13 antibody inhibitor for treating dry eye
STERN MICHAEL E2 citations55
US9457060B2Oct 4, 2016
Therapeutic methods using cyclosporine components
STERN MICHAEL E0 citations51
US8491912B2Jul 23, 2013
Methods of treating ocular and other diseases with Syn-134R polypeptide
STERN MICHAEL E0 citations48